- Motley Fool•3 days ago
Endo International, Horizon Pharma, and Valeant Pharmaceuticals have all run into a proverbial buzz saw this year. But these beaten-down specialty pharma stocks may now be too cheap too ignore.
- Barrons.com•4 days ago
Stocks like Valeant Pharmaceuticals International (VRX), Mallinckrodt (MNK), Endo International (ENDP), and Allergan (AGN) have been hit hard this year by concerns about how their drugs are priced. Guggenheim analyst Louise Chen and team, however, argue that the drug-pricing overhang could be on its way out. The Medicare Part B Demo received 1,300 comments demonstrating how controversial any changes to drug pricing could be...In our coverage universe, the high priced drug debate has weighed on Allergan, Shire (SHPG), Valeant Pharmaceuticals International, Endo International, Mallinckrodt and Jazz Pharmaceuticals (JAZZ).
Endo International plcNasdaqGS
After hours: 17.500.00 (0.00%) as of 4:44 PM EDT
|Bid||17.40 x 500|
|Ask||17.81 x 800|
|52wk Range||12.56 - 88.54|
|Day's Range||17.30 - 18.18|
|Avg Vol (3m)||9,839,247|
As of 4:00 PM EDT. Market closed.